A novel antifungal analog peptide derived from protaetiamycine

Molecules and Cells

Volumn 28, Issue 5, 2009, Pages 473-477

  Lee, Juneyoung ^a   Hong, Hyun Joo ^a   Kim, Jin Kyoung ^b   Hwang, Jae Sam ^c   Kim, Yangmee ^b   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

^b Konkuk University   (South Korea)

^c National Institute of Animal Science   (South Korea)

Author keywords

Analog peptide; Antifungal peptide; Pore forming mechanism; Protaetiamycin

Indexed keywords

ANTIFUNGAL AGENT; FLUORESCEIN ISOTHIOCYANATE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN 9PBW2; PROTEIN 9PBW4; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FLAVUS; BEETLE; CANDIDA ALBICANS; CONTROLLED STUDY; FLOW CYTOMETRY; FUNGAL STRAIN; HYDROPHOBICITY; MALASSEZIA FURFUR; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; PEPTIDE SYNTHESIS; PROTAETIA BREVITARSIS; TRICHOSPORON BEIGELII;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CELL MEMBRANE PERMEABILITY; DEFENSINS; DEXTRANS; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; INSECT PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDES;

PROTAETIA BREVITARSIS;

EID: 72949093131     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-009-0155-3     Document Type: Article

References (42)

1. B.D. Alexander J.R. Perfect 1997 Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches Drugs 54 657 678
2. O.S. Belokoneva H. Satake E.L. Mal'tseva N.P. Pal'mina E. Villegas T. Nakajima G. Corzo 2004 Pore formation of phospholipid membranes by the action of two hemolytic arachnid peptides of different size Biochim. Biophys. Acta 1664 182 188
3. M.P. Bohrer W.M. Deen C.R. Robertson J.L. Troy B.M. Brenner 1979 Influence of molecular configuration on the passage of macromolecules across the glomerular capillary wall J. Gen. Physiol. 74 583 593
4. H.G. Boman 1995 Peptide antibiotics and their role in innate immunity Annu. Rev. Immunol. 13 61 92
5. D.W. Denning 1991 Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host J. Antimicrob. Chemother. 28 SupplB 1 16
6. M. Ellis M. Richardson B. de Pauw 2000 Epidemiology Hosp. Med. 61 605 609
7. C. Gyurko U. Lendenmann E.J. Helmerhorst R.F. Troxler F.G. Oppenheim 2001 Killing of Candida albicans by histatin 5: cellular uptake and energy requirement Antonie Van Leeuwenhoek 79 297 309
8. R.E. Hancock K.L. Brown N. Mookherjee 2006 Host defence peptides from invertebrates-emerging antimicrobial strategies Immunology 211 315 322
9. +-coupled oligopeptide absorption in enterocytes from guinea-pig ileum J. Physiol. 511 573 586
10. J.A. Hoffmann 1995 Innate immunity of insects Curr. Opin. Immunol. 7 4
11. T.P. Hopp K.R. Woods 1981 Prediction of protein antigenic determinants from amino acid sequences Proc. Natl. Acad. Sci. USA 78 3824 3828
12. J. Hwang B. Kang S.R. Kim E. Yun K. Park J.P. Jeon S. Nam H. Suh M.Y. Hong I. Kim 2008 Molecular characterization of a defensin-like peptide from larvae of a beetle, Protaetia brevitarsis Int. J. Ind. Entomol. 17 131 135
13. P. Jungblut B. Thiede 1997 Protein identification from 2-DE gels by MALDI mass spectrometry Mass Spectrom. Rev. 16 145 162
14. R.S. Klein C.A. Harris C.B. Small B. Moll M. Lesser G.H. Friedland 1984 Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome N. Engl. J. Med. 311 354 358
15. D.P. Kontoyiannis E. Mantadakis G. Samonis 2003 Systemic mycoses in the immunocompromised host: an update in antifungal therapy J. Hosp. Infect. 53 243 258
16. B.J. Kullberg B.E. de Pauw 1999 Therapy of invasive fungal infections Neth. J. Med. 55 118 127
17. T.C. Laurent K.A. Granath 1967 Fractionation of dextran and Ficoll by chromatography on Sephadex G-200 Biochim. Biophys. Acta 136 191 198
18. J. Lee D.G. Lee 2009 Antifungal properties of a peptide derived from the signal peptide of the HIV-1 regulatory protein Rev. FEBS Lett. 583 1544 1547
19. J.Y. Lee S.A. Lee J.K. Kim C.B. Chae Y. Kim 2009 Interaction models of substrate peptides and beta-secretase studied by NMR spectroscopy and molecular dynamics simulation Mol. Cells 27 651 656
20. J. Lee Y. Choi E.R. Woo D.G. Lee 2009 Isocryptomerin, a novel membrane-active antifungal compound from Selaginella tamariscina Biochem. Biophys. Res. Commun.
21. A. Makovitzki Y. Shai 2005 pH-dependent antifungal lipopeptides and their plausible mode of action Biochemistry 44 9775 9784
22. A. Makovitzki D. Avrahami Y. Shai 2006 Ultrashort antibacterial and antifungal lipopeptides Proc. Natl. Acad. Sci. USA 103 15997 16002
23. J.M. Mancheño M. Oñderra A. Martínez del Pozo P. Díaz-Achirica D. Andreu L. Rivas J.G. Gavilanes 1996 Release of lipid vesicle contents by an antibacterial cecropin Amelittin hybrid peptide Biochemistry 35 9892 9899
24. M.E. Mangoni A. Aumelas P. Charnet C. Roumestand L. Chiche E. Despaux G. Grassy B. Calas A. Chavanieu 1996 Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation FEBS Lett. 383 93 98
25. B. Merrifield 1986 Solid phase synthesis Science 232 341 347
26. P.K. Mukherjee J. Chandra D.M. Kuhn M.A. Ghannoum 2003 Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols Infect. Immun. 71 4333 4340
27. F.C. Odds A.J. Brown N.A. Gow 2003 Antifungal agents: mechanisms of action Trends Microbiol 11 272 279
28. Y. Park D.G. Lee S.H. Jang E.R. Woo H.G. Jeong C.H. Choi K.S. Hahm 2003 A Leu-Lys-rich antimicrobial peptide: activity and mechanism Biochim. Biophys. Acta 1645 172 182
29. S.C. Park M.H. Kim M.A. Hossain S.Y. Shin Y. Kim L. Stella J.D. Wade Y. Park K.S. Hahm 2008 Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions Biochim. Biophys. Acta 1778 229 241
30. C. Pina-Vaz F. Sansonetty A.G. Rodrigues S. Costa-Oliveira C. Tavares J. Martinez-de-Oliveira 2001 Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals Clin. Microbiol. Infect. 7 609 618
31. R. Ramani A. Ramani S.J. Wong 1997 Rapid flow cytometric susceptibility testing of Candida albicans J. Clin. Microbiol. 35 2320 2324
32. S. Rex 1996 Pore formation induced by the peptide melittin in different lipid vesicle membranes Biophys. Chem. 58 75 85
33. M.E. Selsted A.J. Ouellette 2005 Mammlian defensins in the antimicrobial immune response Nat. Immunol. 6 551 557
34. D.J. Sheehan C.A. Hitchcock C.M. Sibley 1999 Current and emerging azole antifungal agents Clin. Microbiol. Rev. 12 40 79
35. S. Shin J.K. Kim J.Y. Lee K.W. Jung J.S. Hwang J. Lee D.G. Lee I. Kim S.Y. Shin Y. Kim 2009 Design of potent 9-mer antimicrobial peptide analogs of protaetiamycine and investigation of mechanism of antimicrobial action J. Pept. Sci.
36. T. Suzuki K. Fujikura T. Higashiyama K. Takata 1997 DNA staining for fluorescence and laser confocal microscopy J. Histochem. Cytochem. 45 49 53 (Pubitemid 27045364)
37. K. Taylor P.E. Barran J.R. Dorin 2008 Structure-activity relationships in beta-defensin peptides Biopolymers 90 1 7
38. E.C. Veerman M. Valentijn-Benz K. Nazmi A.L. Ruissen E. Walgreen-Weterings J. van Marle A.B. Doust W. van't Hof J.G. Bolscher A.V. Amerongen 2007 Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane J. Biol. Chem. 282 18831 18841
39. A.N. Volkoff J. Rocher E. D'Alencon M. Bouton I. Landais E. Quesada-Moraga A. Vey P. Fournier K. Mita G. Devauchelle 2003 Characterization and transcriptional profiles of three Spodoptera frugiperda genes encoding cysteine-rich peptides. A new class of defensin-like genes from lepidopteran insects? Gene 13 43 53
40. O. Wesołowska K. Michalak J. Maniewska A.B. Hendrich 2009 Giant unilamellar vesicles - a perfect tool to visualize phase separation and lipid rafts in model systems Acta Biochim. Pol. 56 33 39
41. M. Zasloff 2002 Antimicrobial peptides of multicellular organisms Nature 415 389 395
42. I. Zelezetsky S. Pacor U. Pag N. Papo Y. Shai H.G. Sahl A. Tossi 2005 Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity Biochem. J. 390 177 188